Abstract
Thrombolysis with intravenous streptokinase, APSAC and tissue plasminogen activator has been shown to improve ventricular function and survival in patients with acute myocardial infarction (1–4). Despite these important advances several problems remain and we may not have achieved the optimal benefit from reperfusion therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gruppo Italiano Per Lo Studio Delia Streptochinasi Nell’Infarcto Miocardio (GISSI). Lancet 1:397–401, 1986.
ISIS-2 Collaborative Group. Lancet 11:349–360, 1988.
AIMS Trial Study Group. Lancet 1 545–549, 1988.
Wilcox, R.G., Olsson, C.G., Skene, A.M. et al. for the ASSET Study Group. Lancet 11:525–530, 1988.
Topol, E.J., Califf, R.M., George, B.S., Kereiakes, D.J., Abbottsmith, C.W., Candela, R.J., Lee, K.L., Pitt, B., Stack, R.S. and O’Neill, W.W. N. Engl. J. Med. 317:581–588, 1987.
Stadius, M.L., Maynard, C., Ftiz, J.K., et al. Circulation 72:292–301, 1985.
Nicklas, J.M., Diltz, E.A., O’Neill, W.W., Bourdillon, P.D.V., Walton, J.A., Jr. and Pitt, B. J. Am. Coll. Cardiol. 10:284–289, 1987.
Fung, A.Y., Lai, P., Topol, E.J., Bates, E.R., Bourdillon, P.D.V., Walton, J.A., Mancini, G.B.J., Kryski, T., Pitt, B. and O’Neill, W.W. Am. J. Cardiol. 58:686–691, 1986.
Coller, B.S. and Scudder, L.E. Blood 66:1456–1459, 1985.
Mickelson, J.K., Simpson, P.J. and Lucchesi, B.R. J. Mol. Cell. Cardiol. (in press).
Romson, J.L., Hood, B.G. and Lucchesi, B.R. J. Pharmacol. Exp. Therap. 227:288–294, 1983.
Jolly, S.R., Kane, W.J., Bailie, M.B., Abrams, G.D. and Lucchesi, B.R. Circ. Res. 54:227–285, 1984.
Lucchesi, B.R. and Mullane, K.M. Ann. Rev. Pharmacol. Toxicol. 26:201–224, 1986.
Werns, S.W. and Lucchesi, B.R. Free Radical Biol. Med. 4:31–37, 1988.
Hill, J.H. and Ward, P.A. J. Exp. Med. 133:885–900, 1975.
Romson, J.L., Hook, B.G., Kunkel, S.L., Abrams, G.D., Schork, M.A. and Lucchesi, B.R. Circulation 67:1016–1023, 1983.
Rosse, R.D., Michael, L.H., Kagiyama, A., Savage, H.E., Hanson, G., Reisberg, M.A., Moake, J.N., Kim, Sh., Giannini, E. and Entman, M.L. Circ. Res. 62:572–584, 1988.
Simpson, P.J., Todd, R.F., III, Fantone, J.C., Mickelson, J.K., Griffin, J.D. and Lucchesi, B.R. J. Clin. Invest. 81:624–629. 1988.
Romson, J.L., Hook, B.G., Rigot, V.H., Schork, M.A., Swanson, D.P. and Lucchesi, B.R. Circulation 66:1002–1011, 1988.
Romson, J.L., Hook, B.G., Kunkel, S.L., Abrams, G.D., Schork, M.A. and Lucchesi, B.R. Circulation 67:1016–1023, 1983.
Ambrosio, G. and Chiariello, M. Cardiovasc. Drugs. 2:609–614, 1988.
Tamura, Y., Chi, L., Driscoll, E., Jr., Hoff, P.T., Freeman, B.A., Gallagher, K.P. and Lucchesi, B.R. Circ. Res. 63:944–959, 1988.
Przyklenk, K. and Kloner, R.A. Basic Res. Cardiol. 82:146–158, 1987.
Chi, L., Tamura, Y., Hoff, P.T., Macha, M., Gallagher, K.P., Schork, M.A. and Lucchesi, B.R. Circ. Res. (in press).
Chesebro, J.H., Knatterud, G., Roberts, R., Borer, J., Cohen, L.S., Dalen, J., Dodge, G.T., Francis, C.K., Hillis, D., Ludbrook, P., Markis, J.E., Mueller, H., Massamani, E.R., Powers, E.R., Rao, A.K., Robertson, T., Ross, A., Ryan, T.J., Sobel, B.E., Willerson, J., Williams, D.O., Zaret, B.L. and Braunwald, E. Circulation 76:142–154, 1987.
Collen, D. and Van de Werf, F. Am. J. Cardiol. 60:431–434, 1987.
Topol, E.J., Califf, R.M., George, B.S. and the TAMI Study Group. Circulation 77:1100–1107, 1988.
Topol, E.J., Ellis, G.S., George, B.S., Bates, E.R., Nabel, E.G., Walton, J.A., Kline, E.M., Pitt, B., Califf, R.M. and the TAMI-4 Study Group. Circulation 78(Suppl II):11–303, 1988(abstr).
Ohlstein, E.H. and Shebuski, R.J. Circulation 76(Suppl IV):IV–153, 1987 (abstr).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Pitt, B., Lucchesi, B. (1989). Myocardial Reperfusion: Role of Adjunctive Agents to Improve Reperfusion and Prevent Reperfusion Injury. In: Morganroth, J., Moore, E.N. (eds) Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents. Developments in Cardiovascular Medicine, vol 100. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1605-3_5
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1605-3_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8888-6
Online ISBN: 978-1-4613-1605-3
eBook Packages: Springer Book Archive